There is no scheduled events at the moment.
From February 02, 2018 to February 05, 2018
Lallemand Pharma is pleased to support as sponsor the XII World Congress on COPD, Asthma & Respiratory Allergy, to take place, February 2-5, 2018, Dubai, UAE, organized by the World Immunopathology Organization (WIPO).
During the congress, Professor Guido Ferlazzo (University of Messina, Italy), will deliver a presentation unveiling new potential mechanisms of action for polyvalent mechanical bacterial lysates, explaining their protective role in the reduction of the exacerbation episodes of both COPD and pediatric asthma.
For more information about WIPO congresses, visit www.wipocis.org
September 09, 2017
Join us at ERS congress in Milano, Italy from September 9th-13th, 2017. Our latest pharmacoeconomic results will be presented at the poster session 137 on September 10th, from 12.50 to 14.40 during the thematic Poster “Pediatric asthma: therapies and comorbidities” :
The poster will be presented by Pr A.Bodajko-Grochowska (Lublin, Poland): “Cost of sublingual bacterial vaccines in the treatment of asthma in children“
Location: Milano, Italy
From June 17, 2017 to June 22, 2017
Lallemand Pharma is proud to announce poster session about EOLIA study during EAACI congress from 17-21 June in Helsinki, Finland.
Pr Andrzej Emeryk (Poland) will present “The influence of polyvalent mechanical bacterial lysate course on Asthma in Children” at 13.30 on June 20th , poster discussion Zone 1: category Asthma, Pediatrics, PDS 24 Pediatric Asthma.
Location: Helsinki, Finland
From April 28, 2017 to May 01, 2017
Location: New-York, USA
September 13, 2013
Lallemand Pharma is proud to announce full session on PMBL during the 15th Anniversary Conference for Allergists, Pulmonologists and Clinical Immunologists in Kazimierz in Poland on September 13th 2013 at 2.30 pm.
The session will be dedicated to Bacterial immunostimulation in respiratory tract infections, COPD and asthma.